WHO identifies Ebola treatments, vaccines be tested in trials amid outbreak
May 28 - The World Health Organization recommended prioritizing three experimental treatments for the Bundibugyo strain of Ebola, including Mapp Biopharmaceutical's MBP134, Regeneron's maftivimab and Gilead Sciences' antiviral remdesivir.
Original Source
Read the full article at Straitstimes →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.